Advisors Asset Management, Inc. - ALLIANCEBERNSTEIN GBL HGH IN ownership

ALLIANCEBERNSTEIN GBL HGH IN's ticker is AWF and the CUSIP is 01879R106. A total of 119 filers reported holding ALLIANCEBERNSTEIN GBL HGH IN in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Advisors Asset Management, Inc. ownership history of ALLIANCEBERNSTEIN GBL HGH IN
ValueSharesWeighting
Q3 2023$1,213,470
-2.7%
125,100
-0.1%
0.03%
+4.0%
Q2 2023$1,247,311
+21.6%
125,232
+18.7%
0.02%
+19.0%
Q1 2023$1,025,343
+197.2%
105,488
+295.9%
0.02%
+250.0%
Q2 2017$345,000
-41.7%
26,643
-43.4%
0.01%
-40.0%
Q1 2017$592,000
-36.3%
47,064
-36.3%
0.01%
-33.3%
Q4 2016$929,000
-10.3%
73,909
-10.0%
0.02%
-11.8%
Q3 2016$1,036,000
-1.0%
82,132
-3.6%
0.02%0.0%
Q2 2016$1,046,000
+0.4%
85,156
-4.7%
0.02%0.0%
Q1 2016$1,042,000
+4.8%
89,397
-3.1%
0.02%
+6.2%
Q4 2015$994,000
+41.6%
92,211
+45.4%
0.02%
+45.5%
Q3 2015$702,000
+14.0%
63,399
+23.8%
0.01%
+37.5%
Q2 2015$616,000
+23.9%
51,227
+29.7%
0.01%
+14.3%
Q1 2015$497,000
+116.1%
39,505
+113.7%
0.01%
+133.3%
Q4 2014$230,000
-17.9%
18,485
-10.3%
0.00%
-25.0%
Q3 2014$280,000
-14.9%
20,604
-10.1%
0.00%
-20.0%
Q2 2014$329,000
-7.6%
22,910
-5.0%
0.01%0.0%
Q1 2014$356,000
+3.2%
24,104
-0.2%
0.01%
-16.7%
Q4 2013$345,000
+91.7%
24,153
+101.5%
0.01%
+100.0%
Q3 2013$180,000
+195.1%
11,989
+195.8%
0.00%
+200.0%
Q2 2013$61,0004,0530.00%
Other shareholders
ALLIANCEBERNSTEIN GBL HGH IN shareholders Q1 2023
NameSharesValueWeighting ↓
McGowan Group Asset Management, Inc. 4,331,110$42,098,3876.68%
Sowa Financial Group, Inc. 562,275$5,4653.91%
SMH CAPITAL ADVISORS INC 33,720$333,0001.98%
KENNEDY INVESTMENT GROUP 308,621$2,999,7981.83%
Vivaldi Capital Management LP 367,594$3,573,0161.08%
Uncommon Cents Investing LLC 257,360$2,501,5390.91%
Independent Wealth Network Inc. 143,280$1,392,6830.89%
Quad-Cities Investment Group, LLC 93,258$906,4700.63%
Vanguard Capital Wealth Advisors 31,000$301,3200.30%
Waterfront Wealth Inc. 77,227$750,6510.24%
View complete list of ALLIANCEBERNSTEIN GBL HGH IN shareholders